ROTH Rothschild and Co

By Dominic Chopping

STOCKHOLM--Swedish private-equity firm Nordic Capital said Monday it has agreed to sell specialty diagnostics company The Binding Site to Thermo Fisher Scientific Inc. in a deal valued at 2.25 billion pounds ($2.61 billion).

Nordic Capital has been the majority owner of The Binding Site since 2011 when it completed the acquisition together with Five Arrows, the alternative assets arm of Rothschild & Co.

Nordic Capital and Five Arrows have now entered a definitive agreement to sell The Binding Site, with the deal expected to be completed in the first half of 2023, subject to closing conditions.

Write to Dominic Chopping at dominic.chopping@wsj.com

(END) Dow Jones Newswires

October 31, 2022 08:02 ET (12:02 GMT)

Rothschild (EU:ROTH)
過去 株価チャート
から 3 2024 まで 4 2024

Rothschild (EU:ROTH)
過去 株価チャート
から 4 2023 まで 4 2024